Michael Grodin D.O.

"My commitment is to provide compassionate, personalized treatment of diseases affecting the retina, vitreous, and macula using state of the art technology. I am dedicated to helping my patients increase their quality of life, whether it's improving or preserving their vision."

Dr. Grodin is a Board-Certified Vitreo-Retinal specialist and surgeon. He specializes in the diagnosis, management, and surgical treatment of all Vitreo-Retinal disorders, including, but not limited to, diabetic retinopathy, vascular occlusive disease, macular degeneration, retinal detachment, macular holes, complicated cataract surgery, ocular infection, and ocular inflammation.

Dr. Grodin is the Director of Clinical Research/Principal Investigator at Katzen Eye Group. He has participated in research and development of ophthalmic surgical simulation as well as most of the major clinical trials investigating the safety and efficacy of anti-VEGF treatments, including Lucentis™ and Macugen™.

He received his Doctorate from Nova Southeastern University and Bachelors’ degrees in Biology and History from Tulane University. Dr. Grodin completed externships in ophthalmology at Munich University, in Munich, Germany, as well as in Vitreo-Retinal surgery at Columbia University’s Edward S. Harkness Eye Institute in New York and Bascom Palmer Eye Institute at the University of Miami.

Dr. Grodin completed postdoctoral ophthalmology training at Michigan State University, and a Vitreo-Retinal surgical fellowship at The National Retina Institute in Towson, Maryland. He is a fellow of the American Osteopathic College of Ophthalmology, as well as a member of the American Academy of Ophthalmology, and the American Society of Retinal Specialists. He is a staff member of the Department of Ophthalmology of Sinai Hospital and Mercy Medical Center.

Aside from ophthalmology, Dr. Grodin enjoys spending time with his wife and two children.